Lexaria Bioscience Corp.

LEXX | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.42

+$0.18 (+5.56%)

At close: Sep 21, 2026, 4:00 PM ET

$3.42

$0 (+0.15%)

After-hours: Sep 21, 2026, 4:10 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+5.56%

(1D)

Rating

Updated: Sep 12, 2026

Fundamentals Average

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $5.66M

1D Range

3.29 3.48

52W Range

2.80 23.25

Valuation (TTM)

PE -0.64

PB 1.19

EV/EBITDA -0.28

Valuation (NTM)

Forward PE N/A

Forward PEG 0.07

Price Target $1.50

Cash Flow

FCF Yield -132.5%

SBC Adj. FCF Yield -139.0%

SBC Impact -4.9%

Margins

Gross Margin 100.0%

Operating Margin -3973.2%

FCF Margin -3866.6%

Growth (CAGR)

Revenue 3Y | 5Y -14.2% | -25.1%

Dil EPS 3Y | 5Y 8.6% | 28.4%

FCF 3Y | 5Y -17.7% | -14.4%

Returns

ROA -161.7%

ROE -160.7%

ROIC -174.0%

Financial Health

Net Cash

$3.62M

Current Ratio 10.60

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Lexaria Bioscience Corp. is a biotechnology company focused on advanced drug delivery. Its proprietary and patented DehydraTECH technology is designed to significantly improve the oral delivery of act...

Sector Healthcare

Industry Biotechnology

Employees 7

IPO Date Jan 11, 2021

Website www.lexariabioscience.com

Fiscal Year September - August

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Oct 28, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$1.50

Downside

-56.14%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞